AIP
BOLD

Ameritas Investment Partners’s Boundless Bio BOLD Stock Holding History

Ameritas Investment Partners’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-618
Closed -$933 – 3375
2025
Q1 		$933 Hold
618
– – ﹤0.01% 3106
2024
Q4 		$1.79K Hold
618
– – ﹤0.01% 3105
2024
Q3 		$2.14K Hold
618
– – ﹤0.01% 3095
2024
Q2 		$2.39K Buy
+618
New +$5.91K ﹤0.01% 3090

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's BOLD Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Boundless Bio (BOLD) in Q2 2025, closing a stake of 618 shares — an estimated $933 sold.

Ameritas Investment Partners first reported a position in BOLD in Q2 2024 and held it in 4 quarters. The position peaked at $2.39K in Q2 2024. 44 funds tracked by Wall St. Rank hold BOLD as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Boundless Bio position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 618 Boundless Bio shares in Q2 2025, an estimated $933.
  • Ameritas Investment Partners first reported a position in Boundless Bio in Q2 2024 and held it in 4 quarters.
  • Ameritas Investment Partners's Boundless Bio position peaked at $2.39K in Q2 2024.
  • 44 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.